Description
Shanghai Wonzigene Biotechnology Co., Ltd. was established in April 2021 with a registered capital of 100,000 yuan. It is a wholly owned subsidiary of Zhejiang Oriental Gene Biological Products Co., LTD. (Science and Technology Board code: 688298).
The company focuses on the innovation and development of in vitro diagnostic reagents in the field of liquid chip
R&d Center Laboratory
Address: Zizhu High-tech Industrial Park, Minhang District, Shanghai
At present, the research and development center has three well-known professors of materials science, immunology and molecular biology, and several doctoral and postgraduate students.
Manufacturing center
Address: Jiading Industrial Zone, Shanghai
The company’s existing production plant area of 3500 square meters, instrument assembly workshop 1500 square meters.
Joint Research and Development Center of new Materials and technologies for in vitro diagnosis
Relying on the National Major Science and Technology Infrastructure for Translational Medicine (Shanghai), the company and Shanghai Jiaotong University jointly established the joint research and Development Center of new materials and technologies for in vitro diagnosis, which is one of the key areas of the “13th Five-Year” national Plan. The platform is committed to the translational research of major diseases such as tumors, the effectiveness verification of drugs, reagents and materials, and the breakthrough and application transformation of key technical problems of large-scale high-end medical equipment.
30 patents have been applied or authorized, including 11 invention patents and more than 20 products under research or registration.
Corporate vision
The company will focus on the deep cultivation of liquid chip technology, and strive to become an outstanding innovator and leader in this technology field.
